PGI25 Cost-Utility Analysis of Telaprevir in Combination With Peginterferon Alpha and Ribavirin in Previously Treated Patients With Chronic Hepatitis C

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.774
https://www.valueinhealthjournal.com/article/S1098-3015(12)02487-4/fulltext
Title : PGI25 Cost-Utility Analysis of Telaprevir in Combination With Peginterferon Alpha and Ribavirin in Previously Treated Patients With Chronic Hepatitis C
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02487-4&doi=10.1016/j.jval.2012.08.774
First page : A330
Section Title : Gastrointestinal Disorders
Open access? : No
Section Order : 285
Categories :
Tags :
Regions :
ViH Article Tags :